This content is current only at the time of printing. This document was printed on 5 July 2020. A current copy is located at https://apvma.gov.au/node/27961
You are here
Regulatory Update #262
Dr Chris Parker appointed as APVMA Chief Executive Officer
Dr Chris Parker was appointed to the permanent position of Chief Executive Officer (CEO) of the APVMA on Wednesday 15 November 2017.
Dr Parker has provided valuable leadership to the agency as our interim CEO since June 2017. The Assistant Minister for Agriculture and Water Resources, Luke Hartsukyer, announced Dr Parker’s five year appointment in a statement available from the Assistant Minister’s website.
TGA to adopt new PIC/S Guide to Good Manufacturing Practice—will you be impacted?
From 1 January 2018 the Therapeutic Goods Administration (TGA) will be adopting the latest version of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) Guide to Good Manufacturing Practice.
Veterinary chemical product manufacturers registered with the APVMA who have their audits completed by the TGA will need to comply with the latest version of the Guide.
All affected manufacturers are encouraged to review the information published by the TGA on their website.
Strengthening ties and advancing innovation in global regulatory science
Our recent Chief Scientist blog summarises how domestic and international collaboration with counterpart regulatory bodies helps to advance our work and build scientific harmonisation.
These themes were discussed during the Chief Scientist's recent participation at the annual Global Summit on Regulatory Science (GSRS2017) in Brasilia, Brazil. Building industry relationships and exploring innovative technologies are important in streamlining and maintaining the quality of our regulatory work.
APVMA collaborating with international counterparts at outreach forum in Tokyo
Last week our CEO, Dr Chris Parker attended the 35th VICH steering committee meeting in Tokyo, Japan. Our attendance at these meetings was as an observer member of VICH, contributing to discussions and promoting coordination between national regulatory agencies.
Dr Parker also took part in the VICH Outreach Forum–an international initiative to harmonise technical requirements and improve information exchange for veterinary medicines. Our participation in forums like VICH is one example of how the APVMA is working to streamline and harmonise regulatory requirements across jurisdictions. Read more about our collaborations with overseas regulators and the work we undertake on joint reviews and assessments.
Reminder—open for public consultation
We regularly seek input throughout chemical registration and review processes, and other operational and regulatory processes. We are currently seeking input on the following open consultations:
- Proposal to amend Schedule 20 of the revised Australia New Zealand Food Standards Code - 28 November 2017
- Trade Advice Notice on the proposed use of the product Ceriax Fungicide containing fluxapyroxad on wheat - 29 November 2017
- Proposed approval of cocamidopropyl betaine in the product Crop Culture Nemo Aquatic Surfactant - 12 December 2017
- Proposed approval of the active cyclaniliprole in the product ISK Cyclaniliprole 50 SL Insecticide - 12 December 2017
- New active constituent Isofetamid - 12 December 2017
- Phone our general enquiries number: +61 2 6210 4701
- Email: email@example.com
- Our mailing address is:
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston, Australian Capital Territory 2604
Add us to your address book